Preferred Label : 4-phenylbutyric acid, sodium salt;
UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;
CAS number : 1716-12-7; NT6K61736T;
Is substance : O;
Origin ID : M0325828;
UMLS CUI : C0718066;
ATC code(s)
CISMeF manual mappings
Currated CISMeF NLP mapping
Related record
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3576423/fr/pheburane-phenylbutyrate-de-sodium-desordres-du-cycle-de-l-uree
2025
false
false
false
France
pharmaceutical solutions
administration, oral
treatment outcome
insurance, health, reimbursement
sodium phenylbutyrate
4-phenylbutyric acid
carbamoyl-phosphate synthase i deficiency disease
citrullinemia
ornithine carbamoyltransferase deficiency disease
evaluation of the transparency committee
phenylbutyrates
4-phenylbutyric acid, sodium salt
---
https://recalls-rappels.canada.ca/fr/avis-rappel/renseignements-importants-sur-innocuite-et-efficacite-albrioza-phenylbutyrate-sodium-et
2024
false
false
false
Canada
French
English
pharmacovigilance note
ursodoxicoltaurine
drug combinations
4-phenylbutyric acid, sodium salt
sodium phenylbutyrate and ursodoxicoltaurine
Safety-Based drug withdrawals
canada
multiple sclerosis
adult
---
https://www.cadth.ca/fr/phenylbutyrate-de-sodium-et-ursodoxicoltaurine
2021
false
false
false
Canada
French
drug evaluation
drug combinations
amyotrophic lateral sclerosis
canada
4-phenylbutyric acid, sodium salt
ursodoxicoltaurine
sodium phenylbutyrate and ursodoxicoltaurine
---
http://www.has-sante.fr/portail/jcms/c_1720968/fr/pheburane-phenylbutyrate-de-sodium
2014
false
France
French
orphan drug production
4-phenylbutyric acid, sodium salt
4-phenylbutyric acid, sodium salt
4-phenylbutyric acid
4-phenylbutyric acid
sodium phenylbutyrate
administration, oral
citrullinemia
carbamoyl-phosphate synthase i deficiency disease
ornithine carbamoyltransferase deficiency disease
treatment outcome
evaluation of the transparency committee
guidelines for drug use
continuity of patient care
therapeutic equivalency
randomized controlled trials as topic
phenylbutyrates
phenylbutyrates
---
http://www.has-sante.fr/portail/jcms/c_1720968/fr/pheburane
http://www.has-sante.fr/portail/jcms/c_1720967/fr/pheburane22012014avisct13341
2014
false
France
French
evaluation of the transparency committee
4-phenylbutyric acid, sodium salt
4-phenylbutyric acid, sodium salt
administration, oral
sodium phenylbutyrate
urea cycle disorders, inborn
carbamoyl-phosphate synthase i deficiency disease
ornithine carbamoyltransferase deficiency disease
4-phenylbutyric acid
4-phenylbutyric acid
continuity of patient care
infant, newborn
infant
child
adolescent
adult
treatment outcome
citrullinemia
phenylbutyrates
phenylbutyrates
guidelines for drug use
---
https://www.ema.europa.eu/medicines/human/EPAR/Pheburane
2013
false
United Kingdom
French
4-phenylbutyric acid, sodium salt
4-phenylbutyric acid, sodium salt
drug approval
europe
treatment outcome
sodium phenylbutyrate
urea cycle disorders, inborn
carbamoyl-phosphate synthase i deficiency disease
ornithine carbamoyltransferase deficiency disease
citrullinemia
administration, oral
hyperammonemia
4-phenylbutyric acid
4-phenylbutyric acid
summary of product characteristics
package leaflet
drug evaluation
syndication feed
drug interactions
pregnancy
breast feeding
prodrugs
phenylacetate
phenylacetic acid
drug evaluation, preclinical
phenylacetates
phenylbutyrates
phenylbutyrates
---
https://www.ema.europa.eu/medicines/human/EPAR/Ammonaps
2011
United Kingdom
English
French
syndication feed
4-phenylbutyric acid
sodium phenylbutyrate
infant
child
adult
treatment outcome
pregnancy
4-phenylbutyric acid, sodium salt
4-phenylbutyric acid, sodium salt
drug evaluation
summary of product characteristics
package leaflet
4-phenylbutyric acid
administration, oral
carbamoyl-phosphate synthase i deficiency disease
ornithine carbamoyltransferase deficiency disease
citrullinemia
urea cycle disorders, inborn
phenylacetic acid
breast feeding
drug interactions
drug approval
europe
phenylacetate
hyperammonemia
phenylacetates
phenylbutyrates
phenylbutyrates
---
http://www.has-sante.fr/portail/display.jsp?id=c_241518
2001
France
French
phenylbutyrates
antineoplastic agents
4-phenylbutyric acid
sodium phenylbutyrate
4-phenylbutyric acid, sodium salt
guidelines for drug use
---
http://www.has-sante.fr/portail/display.jsp?id=c_241518
2001
France
French
antineoplastic agents
phenylbutyrates
ornithine carbamoyltransferase deficiency disease
child
carbamoyl-phosphate synthase (ammonia)
argininosuccinate synthase
citrullinemia
infant, newborn
ornithine carbamoyltransferase
infant
sodium phenylbutyrate
4-phenylbutyric acid, sodium salt
4-phenylbutyric acid
evaluation of the transparency committee
---